FDA Authorizes Use Of Pfizer COVID-19 Vaccine In young Kids

While authorized for emergency use, the Pfizer trial sample was small and long-term safety of the vaccine is still in question

(Pfizer via AP, File)


The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine.

The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week.

One more regulatory hurdle remains: On Tuesday, advisers to the Centers for Disease Control and Prevention will make more detailed recommendations on which youngsters should get vaccinated, with a final decision by the agency’s director expected shortly afterwards.

“Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” Dr. Janet Woodcock, the acting FDA commissioner, said in a statement. “Our comprehensive and rigorous evaluation of the data pertaining to the vaccine’s safety and effectiveness should help assure parents and guardians that this vaccine meets our high standards.”

Read More

Leave a Reply


Marine Who Thwarted Robbery In Now Viral Video Wears ‘Let’s Go Brandon’ Shirt To Accept Citizens Award

Wabbits Smarter Than Americans?